{"id":"NCT02234843","sponsor":"Bayer","briefTitle":"EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis","officialTitle":"Multicenter, Open-label, Active-controlled, Randomized Study to Evaluate the Efficacy and Safety of an age-and Body Weight-adjusted Rivaroxaban Regimen Compared to Standard of Care in Children With Acute Venous Thromboembolism","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-11-13","primaryCompletion":"2019-01-30","completion":"2019-01-30","firstPosted":"2014-09-09","resultsPosted":"2020-04-01","lastUpdate":"2020-04-01"},"enrollment":500,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Venous Thromboembolism"],"interventions":[{"type":"DRUG","name":"Rivaroxaban (Xarelto, BAY59-7939)","otherNames":[]},{"type":"DRUG","name":"Rivaroxaban (Xarelto, BAY59-7939)","otherNames":[]},{"type":"DRUG","name":"Standard of Care","otherNames":[]}],"arms":[{"label":"BAY59-7939","type":"EXPERIMENTAL"},{"label":"Standard of Care","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate comparative efficacy and safety of rivaroxaban to standard of care in children with acute venous thromboembolism.","primaryOutcome":{"measure":"Incidence Rates of All Symptomatic Recurrent Venous Thromboembolism During the Main Treatment Period","timeFrame":"During the main study treatment period (i.e., 3 months, except for children with central venous catheter venous thromboembolism (CVC-VTE) aged <2 years for whom it was 1 month)","effectByArm":[{"arm":"Rivaroxaban Group","deltaMin":1.2,"sd":null},{"arm":"Comparator Group","deltaMin":3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.1509"}]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":9},"locations":{"siteCount":109,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Canada","China","Finland","France","Germany","Hong Kong","Hungary","Ireland","Israel","Italy","Japan","Mexico","Netherlands","Portugal","Russia","Singapore","Slovakia","Spain","Sweden","Switzerland","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["36006613","33351120","33002131","31699660","31420317","30598642"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":35,"n":162},"commonTop":["Headache","Epistaxis","Pyrexia","Vomiting","Nasopharyngitis"]}}